Corporate calendar for Kairos Pharma, Ltd. (KAPA): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, Inc., the enterprise officially adopted its current identity as Kairos Pharma, Ltd.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $91M | |
| 2026-09-15 | ||
| 2026-09-15 | $17M |
Stock Splits
| Date | Ratio |
|---|---|
| 2026-09-01 | 1:7 |
Price
| Price | $1.81 |
| Market Cap | $6M |
| Exchange | AMEX |
| Country | US |
Related companies: ALLR · BCTX · CASI · CING · CLSD · ENTO · LEXX
Explore sector: Healthcare · Biotechnology
More sections of KAPA: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks